AlphaQuest LLC Purchases 18,874 Shares of Encompass Health Corporation $EHC

AlphaQuest LLC boosted its position in Encompass Health Corporation (NYSE:EHC) by 170.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,916 shares of the company’s stock after purchasing an additional 18,874 shares during the quarter. AlphaQuest LLC’s holdings in Encompass Health were worth $3,800,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in EHC. Royal Bank of Canada lifted its holdings in shares of Encompass Health by 21.5% during the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after buying an additional 15,677 shares in the last quarter. Millennium Management LLC increased its position in Encompass Health by 38.4% during the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after acquiring an additional 25,574 shares during the period. Caxton Associates LLP acquired a new stake in Encompass Health in the 1st quarter worth about $259,000. Signaturefd LLC boosted its holdings in Encompass Health by 29.1% in the 2nd quarter. Signaturefd LLC now owns 869 shares of the company’s stock valued at $107,000 after purchasing an additional 196 shares during the period. Finally, USA Financial Formulas acquired a new position in shares of Encompass Health during the 2nd quarter worth approximately $258,000. Institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on EHC. Barclays lifted their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. UBS Group upped their target price on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Finally, Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Encompass Health has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Stock Performance

Encompass Health stock opened at $94.44 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. The stock has a market cap of $9.50 billion, a PE ratio of 17.85, a P/E/G ratio of 1.54 and a beta of 0.74. Encompass Health Corporation has a 12-month low of $92.53 and a 12-month high of $127.99. The business’s 50-day moving average price is $106.45 and its two-hundred day moving average price is $114.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.04. The company had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.48 billion. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period last year, the company posted $1.03 EPS. As a group, analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.